mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-09 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-09 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-07 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |